Silexion Therapeutics Share Price

SLXN

KYG1281K1489

Market Closed - Nasdaq 21:00:00 13/11/2026 GMT			5-day change	1st Jan Change
1.980 ^USD	-25.56%		-43.18%	-79.07%

21/08/24	Moringa Acquisition Corp Announces Cessation of Ilan Levin as Chief Executive Officer	CI
21/08/24	Moringa Acquisition Corp Announces Cessation of Gil Maman as Chief Financial Officer	CI

Valuation: Silexion Therapeutics

Market Cap	32.57M 29.51M 27.3M 24.63M 46.42M 3.07B 48.05M 328M 130M 1.64B 122M 120M 5.21B	P/E 2022	256x	P/E 2023	253x
Enterprise Value	35.3M 31.99M 29.59M 26.7M 50.31M 3.33B 52.08M 355M 141M 1.78B 132M 130M 5.64B	EV / Sales 2022	-	EV / Sales 2023	-
Free-Float	-	Yield 2022 *	-	Yield 2023	-

* Estimated data More valuation ratios

Latest news: Silexion Therapeutics

21/08/24	Moringa Acquisition Corp Announces Cessation of Ilan Levin as Chief Executive Officer	CI
21/08/24	Moringa Acquisition Corp Announces Cessation of Gil Maman as Chief Financial Officer	CI
21/08/24	Moringa Acquisition Corp Announces Board Changes	CI
14/08/24	Moringa Acquisition Corp(NasdaqCM:MACA) dropped from NASDAQ Composite Index	CI
14/08/24	Silexion Ltd. completed the acquisition of Moringa Acquisition Corp from Yakira Capital Management, Inc., Linden Capital L.P., Moringa Sponsor, LP and others in a reverse merger transaction.	CI
13/08/24	Moringa Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Moringa Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04/24	Moringa Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/02/24	Silexion Ltd. entered into a business combination agreement to acquire Moringa Acquisition Corp for $68.9 million.	CI
14/11/23	Moringa Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
17/08/23	Moringa Acquisition Corp announced that it has received $0.154506 million in funding	CI
14/08/23	Moringa Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
06/08/23	Holisto LTD cancelled the acquisition of Moringa Acquisition Corp from Moringa Sponsor, LP and others.	CI

More news

Press Releases: Silexion Therapeutics

15/08/24	Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination	AQ
22/02/24	Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp	AQ
15/08/23	MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION	AQ
21/06/23	MORINGA ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
31/03/23	MORINGA ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ

More press releases

Managers and Directors: Silexion Therapeutics

Manager	Title	Age	Since
Gil Maman DFI	Director of Finance/CFO	43	23/09/2020

Director	Title	Age	Since
Ruth Alon BRD	Director/Board Member	74	-
Eric Brachfeld BRD	Director/Board Member	-	31/01/2021

More insiders

Moringa Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search on technology-based businesses that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection. It has no operations and generates no revenues.

Employees

Sector

More about the company

Quotes

Date	Price	Change
13/11/26	US$1.980	-25.56%
12/11/26	US$2.660	-17.65%
11/11/26	US$3.230	+23.58%
10/11/26	US$2.614	-12.11%
09/11/26	US$2.974	-14.67%

Delayed Quote Nasdaq

More quotes

3 years	1.82	13.56
5 years	1.82	13.56
10 years	1.82	13.56

	2022	2023
Net sales	-	-
Net income	584K 529K 490K 442K 832K 55.07M 862K 5.88M 2.33M 29.42M 2.19M 2.15M 93.37M	263K 238K 221K 199K 375K 24.8M 388K 2.65M 1.05M 13.25M 987K 966K 42.06M
Net Debt	1.13M 1.02M 947K 855K 1.61M 107M 1.67M 11.38M 4.51M 56.93M 4.24M 4.15M 181M	2.73M 2.48M 2.29M 2.07M 3.89M 258M 4.03M 27.52M 10.91M 138M 10.26M 10.04M 437M

Silexion Therapeutics Share Price

Stocks

SLXN

KYG1281K1489

Valuation: Silexion Therapeutics

Chart: Silexion Therapeutics

Latest news: Silexion Therapeutics

Press Releases: Silexion Therapeutics

Quotes and Performance

Price Extremes

Managers and Directors: Silexion Therapeutics

Latest insider transactions

Financials

Company Profile

Quotes

1 day	-25.56%
Current month	-79.07%
Current year	-79.07%